Katherine Goodrich's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals Inc | Katherine Goodrich | Director | 13 Nov 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | ||
Tarsus Pharmaceuticals Inc | Katherine Goodrich | Director | 13 Nov 2024 | 6,700 | 6,700 | - | - | Restricted Stock Units |